Chlorpheniramine Maleate Market

Global Chlorpheniramine Maleate Market Size, Share & Trends Analysis Report, By Dosage Form (Injection, Syrup, Tablets, Powder, and Others), By Application (Allergy, Hay Fever, Common Cold, and Itchy Throat/Skin), By End-User (Hospitals, Clinics, and Research Institutes), Forecast (2021-2027)
    Update Available - Forecast 2024-2030   

Published: Jul 2023 | Report Code: OMR2025337 | Category : Pharmaceuticals | Delivery Format: /

The Global chlorpheniramine maleate market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). The high incidence of allergic conditions such as rhinitis has been attributed to the positive growth of the market. Chlorpheniramine maleate is an alkylamine antihistamine that is used in the treatment of allergic conditions such as rhinitis and urticaria. This compound blocks histamine during allergic reactions, thus preventing allergic symptoms namely runny nose, watery eyes, sneezing, and itching. Moreover, the high demand for over-the-counter (OTC) products and the development of healthcare infrastructure further propel market growth. However, factors such as side effects associated with the use of antihistamines and lack of awareness about allergic reactions amongst people are expected to hinder the market growth. The introduction of novel therapies by R&D with fewer side effects and more efficacy provide opportunities in near future. 

The market is segmented on the basis of dosage form, application, and region. On the basis of the dosage form, the market is segmented into injection, syrup, tablets, and powder, and others, which include granules for the solution and liquid-filled capsules. Based on the application, the market is divided into allergy, hay fever, common cold, itchy throat/skin. On the basis of end-user, the market is categorized into hospitals, clinics, and research institutes. 

Market Coverage

  • The market number available for – 2020-2027
  • Base year- 2020
  • Forecast period- 2021-2027
  • Segment Covered
  • Regions Covered- Globally

Competitive Landscape: AstraZeneca PLC, GlaxoSmithKline plc, Merck KGaA, and Sanofi S.A., among others.

Key questions addressed by the report

  • What is the market growth rate?
  • Which segment and region dominates the market in base year?
  • Which segment and region will project fastest growth in the market?
  • How COVID-19 impacted the market?

o Recovery Timeline

o Deviation from pre-COVID forecast

o Most affected region and segment

  • Who is the leader in the market?
  • How players are addressing challenges to sustain growth?
  • Where is the investment opportunity?

Global Chlorpheniramine Maleate Market Report Segmentation

By Dosage Form

Injection

Syrup

Tablets

Powder

Others

By Application

Allergy

Hay Fever

Common Cold

Itchy Throat/Skin

By End-User

Hospitals

Clinics

Research Institutes

Global Chlorpheniramine Maleate Market by Region

North America

  • United States
  • Canada

Europe

  • UK
  • Germany
  • Italy
  • Spain
  • France
  • Rest of Europe 

Asia-Pacific

  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific